Craig M. Crews awarded the 2022 Connecticut Medal of Technology
![craig crews](https://mcdb.yale.edu/sites/default/files/crews-250_thumb.jpg)
May 19, 2022
Craig Crews is awarded for pioneering research that launched the pharmaceutical field of Targeted Protein Degradation (TPD). TPD is hailed as a new paradigm for drug development and will almost certainly lead to novel therapeutics. Described as an exceptionally creative scientist, with an eagerness to ask piercing, mechanism-based questions, and a commitment to evidence-based, first-rate, definitive science, he has had a profound translational impact in drug development.